Abstract
Accurate hemostasis during neck surgery plays a key role in achieving successful patient’s outcome. In addition to traditional hemostatic methods, several topical hemostatic agents (THA) and tissue adhesives (TA) have been recently developed to reduce time in operating room and complications. THA may decrease intraoperative bleeding and facilitate modern surgical technologies such as minimally invasive surgery, video-assisted, endoscopic and robotic procedures. A large number of commercial and blood bank prepared fibrin sealants are commonly used in a variety of surgical settings (biologically active agents, active hemostatics): these products are somehow similar in composition but actually vary widely as to components and preparation methods. THA include physical passive agents (such as cellulose-based hemostatic agents, gelatin-based hemostatic agents and collagen-based hemostatic agents), sealants (TA, such as cyanoacrylates, PEG – polyethylene glycol hydrogels, glutaraldehyde-albumina sealants), and Combined products. Adverse effects and complications from THA and TA are generally uncommon. The ideal hemostatic should be safe, effective, practical, and cost-effective. The choice of which THA to use depends upon the character, amount, and location of bleeding; type of surgical procedure; the availability of a given agent; cost considerations; and surgeon preference and habits. Surgeons should be familiar with THA to ensure an optimal use in theater.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ellis H (2001) A history of surgery. Greenwich Medical Media, London
Giddings AEB (1998) The history of thyroidectomy. J R Soc Med 91(Suppl 33):3–6
Welbourn RB (1990) The thyroid. In: The history of endocrine surgery. Praeger, New York, pp 19–27
Halsted WS (1920) The operative story of goitre. The author’s operation. Johns Hopkins Hosp Rep 19:71–257
Harvey SC (1929) The history of haemostasis. Hoeber, New York
Welbourn RB (1996) Highlights from endocrine surgical history. World J Surg 20:603–612
Thompson NW, Olsen WR, Hoffman GL (1973) The continuing development of the technique of thyroidectomy. Surgery 73:913–927
Masci E, Santoleri L, Belloni F et al (2011) Topical hemostatic agents in surgical practice. Transfus Apher Sci 45:305–311
Lacoste L, Gineste D, Karayan J et al (1993) Airway complications in thyroid surgery. Ann Otol Rhinol Laryngol 102:441–446
Shaha AR, Jaffe BM (1994) Practical management of post-thyroidectomy hematoma. J Surg Oncol 57:235–238
Shandilya M, Kieran S, Walshe P et al (2006) Cervical haematoma after thyroid surgery: management and prevention. Ir Med J 99:266–268
Testini M, Marzaioli R, Lissidini G et al (2009) The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study. Langenbecks Arch Surg 394(5):837–842
Calò PG, Pisano G, Piga G et al (2010) Postoperative hematomas after thyroid surgery. Incidence and risk factors in our experience. Ann Ital Chir 81:343–347
Reeve T, Thompson NW (2000) Complications of thyroid surgery: how to avoid them, how to manage them, and observations on their possible effect on the whole patient. World J Surg 24:971–975
Rosato L, Avenia N, Bernante P et al (2004) Complications of thyroid surgery: analysis of a multicentric study on 14, 934 patients operated on in Italy over 5 years. World J Surg 28:271–276
Samudrala S (2008) Topical hemostatic agents in surgery: a surgeon’s perspective. AORN J 88(3):S2–S11
Peralta E, Sanfey H, Collins KA (2014) Overview of topical hemostatic agents and tissues adhesives used in the operating room. http://www.uptodate.com, Topic 15069 Version 9.0
Lai A, Davidson N, Galloway SW et al (2014) Perioperative management of patients on new oral anticoagulants. Br J Surg 101(7):742–749
Spotnitz WD, Mintz PD, Avery N et al (1987) Fibrin glue from stored human plasma. An inexpensive and efficient method for local blood bank preparation. Am Surg 53:460–464
Lombardi CP, Bracaglia R, Revelli L et al (2011) Aesthetic result of thyroidectomy: evaluation of different kinds of skin suture. Ann Ital Chir 82(6):449–455; discussion 455–456
Mannucci PM (1998) Hemostatic drugs. N Engl J Med 339(4):245
Sudmann B, Bang G, Sudmann E (2006) Histologically verified bone wax (beeswax) granuloma after median sternotomy in 17 of 18 autopsy cases. Pathology 38:138
Vestergaard RF, Nielsen PH, Terp KA (2014) Effect of hemostatic material on sternal healing after cardiac surgery. Ann Thorac Surg 97:153
Spotnitz WD, Burks S (2008) Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 48:1502
Schoenecker JG, Johnson RK, Fields RC et al (2003) Relative purity of thrombin-based hemostatic agents used in surgery. J Am Coll Surg 197(4):580
Achneck HE, Sileshi B, Jamiolkowski RM et al (2010) A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg 251:217
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Revelli, L., Tempera, S.E., Bellantone, C., Raffaelli, M., Lombardi, C.P. (2016). Topical Hemostatic Agents. In: Lombardi, C., Bellantone, R. (eds) Minimally Invasive Therapies for Endocrine Neck Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-20065-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-20065-1_20
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20064-4
Online ISBN: 978-3-319-20065-1
eBook Packages: MedicineMedicine (R0)